Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease

Author： Matzner Ulrich   Matthes Frank   Weigelt Cecilia   Andersson Claes   Eistrup Carl   Fogh Jens   Gieselmann Volkmar  

Publisher： Springer Publishing Company

ISSN： 0946-2716

Source： Journal of Molecular Medicine, Vol.86, Iss.4, 2008-04, pp. : 433-442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Recent Developments in Therapeutic Approaches for Lysosomal Storage Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 1-19

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Approaches for Lysosomal Storage Diseases: A Patent Update

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 2, 2013-08 ,pp. : 91-109

Bentham Science Publishers

Access to resources Recommend Favorite

New strategies for the treatment of lysosomal storage diseases (Review)

By Parenti Giancarlo   Pignata Claudio   Vajro Pietro   Salerno Mariacarolina  

International Journal of Molecular Medicine, Vol. 31, Iss. 1, 2013-01 ,pp. : 11-20

Spandidos Publications

Access to resources Recommend Favorite

Gene Transfer Strategies for Correction of Lysosomal Storage Disorders

By  

Acta Haematologica, Vol. 110, Iss. 2-3, 2003-10 ,pp. : 71-85

Karger

Access to resources Recommend Favorite

Metallothioneins are neuroprotective agents in lysosomal storage disorders

By  

ANNALS OF NEUROLOGY, Vol. 83, Iss. 2, 2018-02 ,pp. : 418-432

John Wiley & Sons Inc

Access to resources Recommend Favorite